Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 532 Records) |
| Query Trace: Hereditary cancer[original query] |
|---|
| Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways. International journal of cancer 2024 9 . Carolina Pires, Inês J Marques, Ana Saramago, Margarida M Moura, Marta Pojo, Rafael Cabrera, Catarina Santos, Francisco Rosário, Diana Lousa, João B Vicente, Tiago M Bandeiras, Manuel R Teixeira, Valeriano Leite, Branca M Cava |
| PMS2 mutation spectra in Norway and risk of cancer for carriers of pathogenic variants. Hereditary cancer in clinical practice 2024 9 22 (1): 20. Wenche Sjursen, Hanne K Hyldebrandt, Liss Anne S Lavik, Bjørn Ivar Haukanes, Sarah Ariansen, Siri Briskemyr, Anna E Sylvander, Marianne T Haavind, Maren F Olsen, Elin S Røyset, Hildegunn Vetti, Astrid Stormorken, Eli Marie Grinded |
| Blood molybdenum level as a marker of cancer risk on BRCA1 carriers. Hereditary cancer in clinical practice 2024 9 22 (1): 19. Milena Matuszczak, Adam Kilja?czyk, Wojciech Marciniak, Ró?a Derkacz, Klaudia Stempa, Piotr Baszuk, Marta Bry?kiewicz, Cezary Cybulski, Tadeusz D?bniak, Gronwald Jacek, Tomasz Huzarski, Marcin Lener, Anna Jakubowska, Sandra Pietrzak, Marek Szwiec, Ma?gorzata Stawicka-Nie?acna, Dariusz Godlewski, Artur Prusaczyk, Andrzej Jasiewicz, Tomasz Kluz, Joanna Tomiczek-Szwiec, Ewa Kilar-Kobierzycka, Monika Sio?ek, Renata Posmyk, Joanna Jarkiewicz-Tretyn, Rodney Scott, Steven Narod, Jan Lubi?s |
| Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification. medRxiv : the preprint server for health sciences 2024 9 . Maria Zanti, Denise G O'Mahony, Michael T Parsons, Leila Dorling, Joe Dennis, Nicholas J Boddicker, Wenan Chen, Chunling Hu, Marc Naven, Kristia Yiangou, Thomas U Ahearn, Christine B Ambrosone, Irene L Andrulis, Antonis C Antoniou, Paul L Auer, Caroline Baynes, Clara Bodelon, Natalia V Bogdanova, Stig E Bojesen, Manjeet K Bolla, Kristen D Brantley, Nicola J Camp, Archie Campbell, Jose E Castelao, Melissa H Cessna, Jenny Chang-Claude, Fei Chen, Georgia Chenevix-Trench, , Don M Conroy, Kamila Czene, Arcangela De Nicolo, Susan M Domchek, Thilo Dörk, Alison M Dunning, A Heather Eliassen, D Gareth Evans, Peter A Fasching, Jonine D Figueroa, Henrik Flyger, Manuela Gago-Dominguez, Montserrat García-Closas, Gord Glendon, Anna González-Neira, Felix Grassmann, Andreas Hadjisavvas, Christopher A Haiman, Ute Hamann, Steven N Hart, Mikael B A Hartman, Weang-Kee Ho, James M Hodge, Reiner Hoppe, Sacha J Howell, , Anna Jakubowska, Elza K Khusnutdinova, Yon-Dschun Ko, Peter Kraft, Vessela N Kristensen, James V Lacey, Jingmei Li, Geok Hoon Lim, Sara Lindström, Artitaya Lophatananon, Craig Luccarini, Arto Mannermaa, Maria Elena Martinez, Dimitrios Mavroudis, Roger L Milne, Kenneth Muir, Katherine L Nathanson, Rocio Nuñez-Torres, Nadia Obi, Janet E Olson, Julie R Palmer, Mihalis I Panayiotidis, Alpa V Patel, Paul D P Pharoah, Eric C Polley, Muhammad U Rashid, Kathryn J Ruddy, Emmanouil Saloustros, Elinor J Sawyer, Marjanka K Schmidt, Melissa C Southey, Veronique Kiak-Mien Tan, Soo Hwang Teo, Lauren R Teras, Diana Torres, Amy Trentham-Dietz, Thérèse Truong, Celine M Vachon, Qin Wang, Jeffrey N Weitzel, Siddhartha Yadav, Song Yao, Gary R Zirpoli, Melissa S Cline, Peter Devilee, Sean V Tavtigian, David E Goldgar, Fergus J Couch, Douglas F Easton, Amanda B Spurdle, Kyriaki Michailid |
| Multiple Myeloma Risk and Outcomes are Associated with Pathogenic Germline Variants in DNA Repair Genes. Blood cancer discovery 2024 9 . Santiago Thibaud, Ryan L Subaran, Scott Newman, Alessandro Lagana, David T Melnekoff, Saoirse Bodnar, Meghana Ram, Zachry Soens, William Genthe, Tehilla Brander, Tarek H Mouhieddine, Oliver Van Oekelen, Jane Houldsworth, Hearn Jay Cho, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa Sanchez, Ajai Chari, Erin Moshier, Sundar Jagannath, Samir Parekh, Kenan On |
| PIK3CA mutation analysis in circulating tumor cells of patients with hormone receptor positive metastatic breast cancer. Biochemistry and biophysics reports 2024 9 39 101805. Elena Marino, Cristian Mauro, Elena Belloni, Marco Picozzi, Valentina Favalli, Maria Cristina Cassatella, Laura Zorzino, Luciano Giacò, Pier Giuseppe Pelicci, Massimo Barberis, Maria Teresa Sandri, Loris Berna |
| The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory. Cancer genomics & proteomics 2024 8 21 (5): 448-463. Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Kevisa Potska, Anastasia Katseli, Christina Ntogka, Georgia Pepe, Dimitra Bouzarelou, Athanasios Papathanasiou, Dimitrios Grigoriadis, Georgios N Tsaousis, Helen Gogas, Theodore Troupis, Konstantinos Papazisis, Ioannis Natsiopoulos, Vassileios Venizelos, Kyriakos Amarantidis, Stylianos Giassas, Christos Papadimitriou, Elena Fountzilas, Maroulio Stathoulopoulou, Anna Koumarianou, Grigorios Xepapadakis, Alexandru Blidaru, Daniela Zob, Oana Voinea, Mustafa Özdo?an, Mahmut Çerkez Ergören, Alinta Hegmane, Eirini Papadopoulou, George Nasioulas, Christos Markopoul |
| Possible link between familial susceptibility to cancer and the level of oxidative stress in thyroid cancer patients. Hereditary cancer in clinical practice 2024 8 22 (1): 15. Ivane Javakhishvili, Kote Mardaleishvili, Maka Buleishvili, Maia Mantskava, Irakli Chkhikvishvili, Sophio Kalmakhelidze, Nina Kipiani, Tamar Sanikid |
| The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024). Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2024 8 38 (4): 292-299. P Kleiblová, J Novotný, D Cibula, V Curtisová, O Dubová, L Foretová, A Germanová, M Janatová, O Havránek, M Hojsáková, M Hudcová, M Koudová, V Krutílková, M Palacova, S Paulich, K Petrakova, J Presl, A Puchmajerová, J Soukupová, M Šenke?íková, Z Šimková, H Št?pánková, I Šubrt, I Tachecí, P Tesner, O Urban, K Veselá, Š Vilímová, Z Vl?ková, M Vo?ka, V Weinberger, M Zikán, M Zimovjanová, Z Klei |
| The Crucial Role of Hereditary Cancer Panel Testing in Unaffected Individuals with a Strong Family History of Cancer: A Retrospective Study of a Cohort of 103 Healthy Subjects. Cancers 2024 7 16 (13): . Lucrezia Pilenzi, Federico Anaclerio, Anastasia Dell'Elice, Maria Minelli, Roberta Giansante, Michela Cicirelli, Nicola Tinari, Antonino Grassadonia, Andrea Pantalone, Simona Grossi, Nicole Canale, Annalisa Bruno, Giuseppe Calabrese, Patrizia Ballerini, Liborio Stuppia, Ivana Antonuc |
| A comprehensive analysis of germline predisposition to early-onset ovarian cancer. Scientific reports 2024 7 14 (1): 16183. Klara Horackova, Petra Zemankova, Petr Nehasil, Michal Vocka, Milena Hovhannisyan, Katerina Matejkova, Marketa Janatova, Marta Cerna, Petra Kleiblova, Sandra Jelinkova, Barbora Stastna, Pavel Just, Tatana Dolezalova, Barbora Nemcova, Marketa Urbanova, Monika Koudova, Jana Hazova, Eva Machackova, Lenka Foretova, Viktor Stranecky, Michal Zikan, Zdenek Kleibl, Jana Soukupo |
| Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study. Lung cancer (Amsterdam, Netherlands) 2024 6 194 107864. Oscar Arrieta, Enrique Caballé-Pérez, Norma Hernández-Pedro, Eunice Romero-Nuñez, José Lucio-Lozada, Cesar Castillo-Ruiz, Karla Acevedo-Castillo, Rosa María Álvarez-Gómez, Carolina Molina-Garay, Marco Jiménez-Olivares, Karol Carrillo-Sánchez, Elvia Cristina Mendoza-Caamal, Andrés F Cardona, Jordi Remon, Carmen Alaez-Vers |
| A Molecular Characterization of the Allelic Expression of the BRCA1 Founder ?9-12 Pathogenic Variant and Its Potential Clinical Relevance in Hereditary Cancer. International journal of molecular sciences 2024 6 25 (12): . Julieta Dominguez-Ortiz, Rosa M Álvarez-Gómez, Rogelio Montiel-Manríquez, Alberto Cedro-Tanda, Nicolás Alcaraz, Clementina Castro-Hernández, Luis Bautista-Hinojosa, Laura Contreras-Espinosa, Leda Torres-Maldonado, Verónica Fragoso-Ontiveros, Yuliana Sánchez-Contreras, Rodrigo González-Barrios, Marcela Angélica De la Fuente-Hernández, María de la Luz Mejía-Aguayo, Ulises Juárez-Figueroa, Alejandra Padua-Bracho, Rodrigo Sosa-León, Gabriela Obregon-Serrano, Silvia Vidal-Millán, Paulina María Núñez-Martínez, Abraham Pedroza-Torres, Sergio Nicasio-Arzeta, Alfredo Rodríguez, Fernando Luna, Fernanda Cisneros-Soberanis, Sara Frías, Cristian Arriaga-Canon, Luis A Herrera-Montal |
| Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases. Breast cancer research and treatment 2024 6 . João Paulo Faria, Juliana Godoy Assumpção, Lorena de Oliveira Matos, Fernanda Caroline Soardi, Gabriel Pissolati Mattos Bretz, Eitan Friedman, Luiz De Mar |
| Mutations in Helicobacter pylori infected patients with chronic gastritis, intestinal type of gastric cancer and familial gastric cancer. Hereditary cancer in clinical practice 2024 6 22 (1): 9. Andrzej Hnatyszyn, Marlena Szalata, Aleksandra Zieli?ska, Karolina Wielgus, Miko?aj Danielewski, Piotr Tomasz Hnatyszyn, Andrzej P?awski, Jaros?aw Walkowiak, Ryszard S?oms |
| Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multi-Site Single-Institution Prospective Study. The Journal of urology 2024 6 101097JU0000000000004089. Mouneeb M Choudry, Adri M Durant, Victoria S Edmonds, Christopher J Warren, Katie L Kunze, Michael A Golafshar, Sarah M Nielsen, Edward D Esplin, Jack R Andrews, N Jewel Samadder, Mark D Tys |
| Haplotype analysis detects MLH1 founder variant in Indian Lynch syndrome patient cohort. Familial cancer 2024 12 24 (1): 13. Harsh Sheth, Jyoti Sadhwani, Abhinav Jain, S G Thenral, Vedam Ramprasad, D Timothy Bish |
| BRCA2 germline mutation carrier with five malignancies: a case report. Hereditary cancer in clinical practice 2024 12 22 (1): 27. Elena Su, Yann Christinat, Thomas McKee, Silvia Azzarello-Burri, Wolfram Jochum, Stefanie Fischer, Christian Rothermun |
| Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background. International journal of molecular sciences 2024 12 25 (23): . Petra Nagy, János Papp, Vince Kornél Grolmusz, Anikó Bozsik, Tímea Pócza, Edit Oláh, Attila Patócs, Henriett Bu |
| Prevalence of the major thyroid cancer-associated syndromes in the United States. medRxiv : the preprint server for health sciences 2024 12 . Samantha L White, Taylor Jamil, Caitlin Bell, Lauren Fishbein, Bryan R Haugen, Christopher R Gignoux, Nikita Pozdey |
| Unraveling the genetic landscape of susceptibility to multiple primary cancers. medRxiv : the preprint server for health sciences 2024 11 . Pooja Middha, Linda Kachuri, Jovia L Nierenberg, Rebecca E Graff, Taylor B Cavazos, Thomas J Hoffmann, Jie Zhang, Stacey Alexeeff, Laurel Habel, Douglas A Corley, Stephen Van Den Eeden, Lawrence H Kushi, Elad Ziv, Lori C Sakoda, John S Wit |
| A genome-wide association study in Swedish colorectal cancer patients with gastric- and prostate cancer in relatives. Hereditary cancer in clinical practice 2024 11 22 (1): 25. Johanna Samola Winnberg, Litika Vermani, Wen Liu, Veronika Soller, Jessada Thutkawkorapin, Mats Lindblad, Annika Lindbl |
| Molecular analysis of BRCA1 and BRCA2 genes in La Rioja (Spain): five new variants. Hereditary cancer in clinical practice 2024 10 22 (1): 22. Raquel Salazar Saez, Miriam Zorrilla, Rosa Sánchez, Ana Cebollero, Isabel Manrique, Alfonso Martín, Leticia de Ávila, Alejandra Lacalle-Emborujo, Samuel Martin-Rodriguez, Iván Bernardo-González, Martina Alon |
| Anticipation in families with MLH1-associated Lynch syndrome. Cancer 2024 10 . Arti S Pandey, Christine Drogan, Dezheng Huo, Kristen Postula, Shreshtha M Garg, Sonia S Kupf |
| Importance of Identifying Physical Manifestations That Are Associated With Hereditary Cancer Predisposition: AXIN2 Mutation in an African American Patient. JCO oncology practice 2024 10 OP2400609. Al-Hafis Adegun, Reid Schalet, Ivan Berezowski, Marie L Bor |
| Reply to Importance of Identifying Physical Manifestations That Are Associated With Hereditary Cancer Predisposition: AXIN2 Mutation in an African-American Patient. JCO oncology practice 2024 10 OP2400713. William Fostier, Ari Horton, Ingrid Winship, Neil Raj |
| Prevalence Estimation of the PALB2 Germline Variant in East Asians and Koreans through Population Database Analysis. Cancers 2024 10 16 (19): . Jong Eun Park, Min-Chae Kang, Taeheon Lee, Eun Hye Cho, Mi-Ae Jang, Dongju Won, Boyoung Park, Chang-Seok Ki, Sun-Young Ko |
| Landscape of Multilocus Inherited Neoplasia Allele Syndrome in Mexican Population. JCO global oncology 2025 1 11 e2400065. Dione Aguilar, María L Garza-Rodríguez, Diana C Pérez-Ibave, Carolina E Muñiz-Garza, Victor Treviño, Cynthia M Villarreal-Garza, Oscar Vidal-Gutiérrez, Carlos H Burciaga-Flor |
| Frequency of somatic and germline variants of predisposition genes in young Chinese women with breast cancer. Breast cancer research and treatment 2025 1 . Yuchun Xu, Qindong Cai, Jing Li, Wenhui Guo, Lili Chen, Minyan Chen, Yuxiang Lin, Yali Wang, Weifeng Cai, Yibin Qiu, Peng He, Shunyi Liu, Chuan Wang, Fangmeng |
| TP53 germline testing and hereditary cancer: how somatic events and clinical criteria affect variant detection rate. Genome medicine 2025 1 17 (1): 3. Paula Rofes, Carmen Castillo-Manzano, Mireia Menéndez, Álex Teulé, Sílvia Iglesias, Elisabet Munté, Mireia Ramos-Muntada, Carolina Gómez, Eva Tornero, Esther Darder, Eva Montes, Laura Valle, Gabriel Capellá, Marta Pineda, Joan Brunet, Lidia Feliubadaló, Jesús Del Valle, Conxi Láza |
- Page last reviewed:Feb 1, 2024
- Content source: